Equipoise and the duty of care in clinical research: A philosophical response to our critics

Journal of Medicine and Philosophy

Volumn 32, Issue 2, 2007, Pages 117-133

  Miller, Paul B ^a   Weijer, Charles ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Duty of care; Equipoise; Harm benefit evaluation

Indexed keywords

CLINICAL RESEARCH; CONFERENCE PAPER; PHILOSOPHY; PROFESSIONALISM; RESEARCH ETHICS; RESPONSIBILITY;

CLINICAL TRIALS; ETHICS, RESEARCH; HUMANS; RESEARCH DESIGN;

EID: 34247137485     PISSN: 03605310     EISSN: 17445019     Source Type: Journal    
DOI: 10.1080/03605310701255735     Document Type: Conference Paper

References (33)

1. Arras, J. D. (2001). 'A method in search of a purpose: The internal morality of medicine,' Journal of Medicine and Philosophy, 26, 643-662.
2. Brody, H. & Miller, F. G. (2003). 'The clinician-investigator: Unavoidable but manageable tension,' Kennedy Institute of Ethics Journal, 13(4), 329-346.
3. Buchanan, D. & Miller, F. G. (2005). 'Principles of early stopping of randomized trials for efficacy: A critique of clinical equipoise and an alternative nonexploitation framework,' Kennedy Institute of Ethics Journal, 15, 161-178.
4. Cox, D., La Caze, M., & Levine, M. (Fall, 2005). 'Integrity,' in E. N. Zalta (Ed.), The Stanford Encyclopedia of Philosophy. [On-line]. Available: http://plato.stanford.edu/archives/fall2005/entries/integrity/(First Accessed February 10, 2006; last accessed March 5, 2007)
5. Emanuel, E. J., Wendler, D., & Grady, C. (2000). 'What makes clinical research ethical?' Journal of the American Medical Association, 283, 2701-2711.
6. Emanuel, E. J., & Miller, F. G. (2001). 'The ethics of placebo-controlled trials - A middle ground,' New England Journal of Medicine, 345, 915-919.
7. Feinberg, J. (1986). Harm to Self. New York: Oxford University Press.
8. Freedman, B. (1987). 'Equipoise and the ethics of clinical research,' New England Journal of Medicine, 317, 141-145.
9. Freedman, B., Fuks, A. & Weijer, C. (1992). 'Demarcating research and treatment: A systematic approach for the analysis of the ethics of clinical research,' Clinical Research, 40, 653-660.
10. Horng, S. & Miller, F. G. (2002). 'Is placebo surgery unethical?' New England Journal of Medicine, 347, 137-139.
11. Horng, S. & Miller, F. G. (2003). 'Ethical framework for the use of sham procedures in clinical trials,' Critical Care Medicine, 31(3)(Supp.), S126-S130.
12. Litton, P. & Miller, F. G. (2005). 'A normative justification for distinguishing the ethics of clinical research from the ethics of medical care,' Journal of Law, Medicine & Ethics, 33, 566-574.
13. London, A. J. & Kadane, J. B. (2003). "Sham Surgery and genuine standard of care: Can the two be reconciled?" American Journal of Bioethics, 3(4), 61-64.
14. London, A. J. (2006a). "Sham Surgery and Reasonable Risks" in David Benator, ed. Cutting to the Core: Exploring The Ethics of Contested Surgeries. New York: Rowman & Littlefield.
15. London, A. J. (2006b). Clinical Equipoise: Foundational Requirement of Fundamental Error?" in Bonnie Steinbock, ed., The Oxford Handbook of Bioethics. New York: Oxford, University Press.
16. Miller, F. G. (2003a). 'Sham surgery: An ethical analysis,' American Journal of Bioethics, 3(4), 41-48.
17. Miller, F. G. (2003b). 'Ethical issues in research with healthy volunteers: Risk-benefit assessment,' Clinical Pharmacology & Therapeutics, 74, 513-515.
18. Miller, F. G. (2004). 'Research ethics and misguided moral intuition,' Journal of Law, Medicine & Ethics, 32, 111-116.
19. Miller, F. G., & Brody, H. (2001). 'The internal morality of medicine: An evolutionary perspective,' Journal of Medicine and Philosophy, 26, 581-599.
20. Miller, F. G., & Brody, H. (2002). 'What makes placebo-controlled trials unethical?' American Journal of Bioethics, 2(2), 3-9.
21. Miller, F. G., & Brody H. (2003). 'A critique of clinical equipoise: Therapeutic misconception in the ethics of clinical trials,' Hastings Center Report, 33(3), 19-28.
22. Miller, F. G. & Rosenstein, D. (2003). 'The therapeutic orientation to clinical trials,' New England Journal of Medicine, 348, 1383-1386.
23. Miller, F. G., Rosenstein, D. L. & DeRenzo, E. G. (1998). 'Professional integrity in clinical research,' Journal of the American Medical Association, 280, 1449-1454.
24. Miller, F. G., & Shorr, A. F. (2002). 'Ethical assessment of industry-sponsored clinical trials,' Chest, 121, 1337-1342.
25. Miller, F. G. & Silverman, H. J. (2004). 'The ethical relevance of the standard of care in the design of clinical trials,' American Journal of Respiratory and Critical Care Medicine, 169, 562-564.
26. Miller, P. B. & Weijer, C. (2003). 'Rehabilitating equipoise,' Kennedy Institute of Ethics Journal, 13(2), 93-118.
27. Miller, P. B. & Weijer, C. (2006a). 'The trust-based obligations of the state and physician-researcher to patient-subjects,' Journal of Medical Ethics, 32, 542-547.
28. Miller, P. B. & Weijer, C. (2006b). 'Fiduciary obligation in clinical research,' Journal of Law, Medicine & Ethics, 34, 424-440.
29. Miller, F. G., Wendler, D., & Wilfond B. (2003). 'When do the federal regulations allow placebo-controlled trials in children?' Journal of Pediatrics, 142, 102-107.
30. Scanlon, T. M. (1998). What We Owe to Each Other. Cambridge, MA: Harvard University Press.
31. Silverman, H. J. & Miller, F. G. (2004). 'Control group selection in critical care randomized trials evaluating interventional strategies: An ethical assessment,' Critical Care Medicine, 32, 852-857.
32. Weijer, C. (2000). 'The ethical analysis of risk,' Journal of Law, Medicine & Ethics, 28, 344-361.
33. Weijer, C. & Miller, P. B. (2004). 'When are research risks reasonable in relation to anticipated benefits?' Nature Medicine, 10, 570-573.